文献
J-GLOBAL ID:202202230772678409
整理番号:22A0806326
キメラ抗原受容体T細胞療法試験および一般集団間のリンパ腫患者における差異【JST・京大機械翻訳】
Differences in lymphoma patients between chimeric antigen receptor T-cell therapy trials and the general population
著者 (11件):
Apaydin Eric A.
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Apaydin Eric A.
(Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA)
,
Richardson Andrea S.
(Southern California Evidence-Based Practice Center, RAND Corporation, Pittsburgh, PA, USA)
,
Baxi Sangita
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Vockley Jerry
(Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA)
,
Akinniranye Olamigoke
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Larkin Jody
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Motala Aneesa
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Motala Aneesa
(Southern California Evidence Review Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA)
,
Hempel Susanne
(Southern California Evidence-Based Practice Center, RAND Corporation, Santa Monica, CA, USA)
,
Hempel Susanne
(Southern California Evidence Review Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA)
資料名:
Clinical and Experimental Medicine
(Clinical and Experimental Medicine)
巻:
22
号:
1
ページ:
151-155
発行年:
2022年
JST資料番号:
W4162A
ISSN:
1591-9528
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
ドイツ (DEU)
言語:
英語 (EN)